|
2025 Journal Article What do clinical practice guidelines say about deprescribing? A scoping reviewLangford, Aili Veronica, Warriach, Imaan, McEvoy, Aisling M., Karaim, Elisa, Chand, Shyleen, Turner, Justin P., Thompson, Wade, Farrell, Barbara J., Pollock, Danielle, Moriarty, Frank, Gnjidic, Danijela, Ailabouni, Nagham J. and Reeve, Emily (2025). What do clinical practice guidelines say about deprescribing? A scoping review. BMJ Quality and Safety, 34 (1), 28-39. doi: 10.1136/bmjqs-2024-017101 |
|
2024 Other Outputs Defining and evaluating chemical restraint use in Metro North HealthFreeman, Chris, Canning, Martin, Ailabouni, Nagham, Hillen, Jodie, Alker, Hunter, Hart, Grace and Soen, Dicky (2024). Defining and evaluating chemical restraint use in Metro North Health. Brisbane, QLD, Australia: The University of Queensland. |
|
2024 Journal Article Co-Designing a Consult Patient Decision Aid for Continuation Versus Deprescribing Cholinesterase Inhibitors in People Living with DementiaAilabouni, Nagham J., Thompson, Wade, Hilmer, Sarah N., Quirke, Lyntara, McNeece, Janet, Bourke, Alice, Furst, Chloe and Reeve, Emily (2024). Co-Designing a Consult Patient Decision Aid for Continuation Versus Deprescribing Cholinesterase Inhibitors in People Living with Dementia. Drugs & Aging, 41 (10), 821-831. doi: 10.1007/s40266-024-01146-5 |
|
2024 Conference Publication Deprescribing and shared decision-making researchScott, Sion, Weir, Kristie Rebecca, Denig, Petra, Ailabouni, Nagham and López-Toribio, María (2024). Deprescribing and shared decision-making research. 12th International Shared Decision Making Conference, Lausanne, Switzerland, 7 - 10 July 2024. London, United Kingdom: BMJ Group. doi: 10.1136/bmjebm-2024-sdc.243 |
|
2024 Conference Publication Co-designing a consult patient decision aid for deprescribing cholinesterase inhibitorsAilabouni, Nagham J., Thompson, Wade, Hilmer, Sarah N., Lyntara, Q., Uirke Janet, M., Bourke, Qcneece Alice, Furst, Chloe and Reeve, Emily (2024). Co-designing a consult patient decision aid for deprescribing cholinesterase inhibitors. 12th International Shared Decision Making Conference, Lausanne, Switzerland, 7 - 10 July 2024. London, United Kingdom: BMJ Group. doi: 10.1136/bmjebm-2024-sdc.4 |
|
2024 Journal Article Comparative risk of gout flares when initiating or escalating various urate‐lowering therapy: a systematic review with network meta‐analysisMaher, Dorsa, Reeve, Emily, Hopkins, Ashley, Tan, Jiun Ming, Tantiongco, Mahsa, Ailabouni, Nagham, Woodman, Richard, Stamp, Lisa, Bursill, David, Proudman, Susanna and Wiese, Michael (2024). Comparative risk of gout flares when initiating or escalating various urate‐lowering therapy: a systematic review with network meta‐analysis. Arthritis Care and Research, 76 (6), 871-881. doi: 10.1002/acr.25309 |
|
2024 Journal Article Utilising a 'Community of Practice' to support pharmacists to work in residential aged care: protocol for a longitudinal evaluationLee, Kenneth, Etherton-Beer, Christopher, Johnson, Jacinta, Lobo, Elton, Wang, Kate, Ailabouni, Nagham, Mavaddat, Nahal, Clifford, Rhonda Marise and Page, Amy Theresa (2024). Utilising a 'Community of Practice' to support pharmacists to work in residential aged care: protocol for a longitudinal evaluation. BMJ open, 14 (5) e076856, 1-9. doi: 10.1136/bmjopen-2023-076856 |
|
2024 Journal Article The drug burden index and level of frailty as determinants of healthcare costs in a cohort of older frail adults in New ZealandDuncan, Shnece, Bergler, Hans Ulrich, Menclova, Andrea, Pickering, John W., Nishtala, Prasad S., Ailabouni, Nagham, Hilmer, Sarah N., Mangin, Dee and Jamieson, Hamish (2024). The drug burden index and level of frailty as determinants of healthcare costs in a cohort of older frail adults in New Zealand. Value in Health Regional Issues, 41, 72-79. doi: 10.1016/j.vhri.2023.11.009 |
|
2024 Journal Article Medicines regimens charted for older people living in residential aged care: a repeated cross-sectional study describing the number of medicines, regimen complexity, high-risk prescribing, and potential underprescribingPage, Amy Theresa, Potter, Kathleen, Lee, Georgie, Almutairi, Hend, Lee, Kenneth, Wang, Kate, Ailabouni, Nagham and Etherton-Beer, Christopher (2024). Medicines regimens charted for older people living in residential aged care: a repeated cross-sectional study describing the number of medicines, regimen complexity, high-risk prescribing, and potential underprescribing. Journal of the American Medical Directors Association, 25 (6) 104944, 11-19. doi: 10.1016/j.jamda.2024.01.013 |
|
2024 Journal Article Partnering with a stakeholder steering group to co‐design the PRIME deprescribing conversation tool: reflections and recommendationsAilabouni, Nagham J., Weir, Kristie Rebecca, Brandt, Nicole, Hanjani, Leila Shafiee, Green, Ariel, Thompson, Wade, Freeman, Christopher R., Mangin, Dee, Bohill, Ruth, Furst, Chloe and Reeve, Emily (2024). Partnering with a stakeholder steering group to co‐design the PRIME deprescribing conversation tool: reflections and recommendations. Basic and Clinical Pharmacology and Toxicology, 134 (1), 121-125. doi: 10.1111/bcpt.13938 |
|
2023 Conference Publication Co-designing The Prime Tool To Empower People Living With Dementia And Their Carers To Initiate Deprescribing ConversationsShafiee Hanjani, Leila, Weir, Kristie, Reeve, Emily, Brandt, Nicole, Tao, Eric and Ailabouni, Nagham J. (2023). Co-designing The Prime Tool To Empower People Living With Dementia And Their Carers To Initiate Deprescribing Conversations. FIP World Congress, Brisbane, QLD Australia, 24 - 28 September 2023. |
|
2023 Conference Publication An International Comparison Of Deprescribing Interventional Studies: How To Determine Factors That Contribute To Translational Deprescribing Success?Elsedfy, Youmna, Mangin, Dee, Jamieson, Hamish, Bergler, Ulrich, Nishtala, Prasad, Weaver, Susan K., Reeve, Emily, Freeman, Christopher R. and Ailabouni, Nagham (2023). An International Comparison Of Deprescribing Interventional Studies: How To Determine Factors That Contribute To Translational Deprescribing Success?. FIP World Congress, Brisbane, QLD Australia, 24 - 28 September 2023. |
|
2023 Conference Publication Top 10 unanswered questions about quality use of medicines in people living with dementiaTan, Edwin, Reeve, Emily, Ailabouni, Nagham, Chenoweth, Lynn, Sawan, Mouna, Nguyen, Tuan Anh, Ellett, Lisa Kalisch, Gilmartin-Thomas, Julia, Sluggett, Janet, Quirke, Lyntara and Hilmer, Sarah (2023). Top 10 unanswered questions about quality use of medicines in people living with dementia. International Social Pharmacy Workshop 2022, Sydney, NSW Australia, 11-14 July 2022. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.sapharm.2023.04.035 |
|
2023 Conference Publication Preventing gout flares when introducing or escalating urate-lowering therapy: a systematic review and network meta-analysisMaher, Dorsa, Reeve, Emily, Hopkins, Ashley, Tan, Jiun Ming, Tantiongco, Mahsa, Ailabouni, Nagham, Woodman, Richard, Stamp, Lisa, Bursill, David, Proudman, Susanna and Wiese, Michael (2023). Preventing gout flares when introducing or escalating urate-lowering therapy: a systematic review and network meta-analysis. 2023 Australian Rheumatology Association (ARA) 63rd Annual Scientific Meeting, Hobart, TAS, Australia, 6–9 May 2023. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/imj.16057 |
|
2023 Conference Publication Attitudes of healthcare professional towards the use of parenteral methotrexate in rheumatoid arthritis patients: a qualitative studyMing, Jiun, Reeve, Emily, Chai, Wern Chern, Ailabouni, Nagham, Proudman, Susanna and Wiese, Michael (2023). Attitudes of healthcare professional towards the use of parenteral methotrexate in rheumatoid arthritis patients: a qualitative study. 2023 Australian Rheumatology Association (ARA) 63rd Annual Scientific Meeting, Hobart, TAS, Australia, 6–9 May 2023. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/imj.16057 |
|
2023 Journal Article Consumer and healthcare professional led priority setting for quality use of medicines in people with dementia: gathering unanswered research questionsReeve, Emily, Chenoweth, Lynn, Sawan, Mouna, Nguyen, Tuan Anh, Kalisch Ellett, Lisa, Gilmartin-Thomas, Julia, Tan, Edwin, Sluggett, Janet K., Quirke, Lyntara S., Tran, Kham, Ailabouni, Nagham, Cowan, Katherine, Sinclair, Ron, de la Perrelle, Lenore, Deimel, Judy, To, Josephine, Daly, Stephanie, Whitehead, Craig and Hilmer, Sarah N. (2023). Consumer and healthcare professional led priority setting for quality use of medicines in people with dementia: gathering unanswered research questions. Journal of Alzheimer's Disease, 91 (3), 933-960. doi: 10.3233/jad-220827 |
|
2023 Journal Article Deprescribing anticholinergic and sedative drugs to reduce polypharmacy in frail older adults living in the community: a randomized controlled trialJamieson, Hamish, Nishtala, Prasad S., Bergler, Hans Ulrich, Weaver, Susan K., Pickering, John W., Ailabouni, Nagham J., Abey-Nesbit, Rebecca, Gullery, Carolyn, Deely, Joanne, Gee, Susan B., Hilmer, Sarah N. and Mangin, Dee (2023). Deprescribing anticholinergic and sedative drugs to reduce polypharmacy in frail older adults living in the community: a randomized controlled trial. The Journals of Gerontology: Series A, 78 (9), 1692-1700. doi: 10.1093/gerona/glac249 |
|
2022 Conference Publication Preventing urate-lowering therapy induced gout flares: a systematic review and network meta-analysisMaher, Dorsa, Reeve, Emily, Tan, Jiun Ming, Tantiongco, Mahsa M., Ailabouni, Nagham J., Hopkins, Ashley M., Woodman, Richard J., Stamp, Lisa, Bursill, David, Proudman, Susanna and Wiese, Michael D. (2022). Preventing urate-lowering therapy induced gout flares: a systematic review and network meta-analysis. APSA-ASCEPT, Perth, WA, Australia, 29 November - 2 December 2022. |
|
2022 Conference Publication Co-designing deprescribing guidelines’ implementation into hospital for people living with dementiaAilabouni, Nagham J., Weir, Kristie, Maher, Dorsa, Hilmer, Sarah, Koeper, Ivanka, Russell, Patrick, Shakib, Sepehr and Reeve, Emily (2022). Co-designing deprescribing guidelines’ implementation into hospital for people living with dementia. APSA-ASCEPT, Perth, WA Australia, 29 November - 2 December 2022. |
|
2022 Conference Publication Attitudes of Rheumatoid Arthritis (RA) patients towards Disease Modifying Anti-rheumatic drugs (DMARD) deprescribingMurray, Lauren, Reeve, Emily, Ailabouni, Nagham, Kalisch Ellett, Lisa and Weise, Michael (2022). Attitudes of Rheumatoid Arthritis (RA) patients towards Disease Modifying Anti-rheumatic drugs (DMARD) deprescribing. The Pharmaceutical Society of Australia, Sydney, Australia, 29-31 July 2022. |
